medilawindia

Delhi, India Founded: 2021 • Age: 5 yrs
Provides drug licensing and regulatory support services for the pharmaceutical industry.

About medilawindia

medilawindia was a Healthcare company based in Delhi (India) founded in 2021. It provides drug licensing and regulatory support services for the pharmaceutical industry. It operates on a B2B model. Its Indian entity Elt Corporate Private Limited reported revenue of β‚Ή1.55 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Regulatory Services and Drug Licensing.

Company details

medilawindia, established in 2021 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, regulatory services, and drug licensing. Provides drug licensing and regulatory support services for the pharmaceutical industry. Adapting to market demands with innovation and client-focused strategies.

Key Metrics
  • Annual Revenue
    ₹1.55 Cr

    FY 2024 · -19% YoY

  • Net Loss
    -₹55.7 Lakh

    FY 2024 · -36% margin

  • EBITDA
    -₹44.6 Lakh

    FY 2024 · -29% margin

Board of directors of Elt Corporate Private Limited (medilawindia)

Elt Corporate Private Limited is the primary company behind medilawindia. The board of Elt Corporate Private Limited currently have 3 directors; the longest-serving is Shruti Jain, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Shruti Jain
DIN 08501794
Director05 Jul 20197 yrs 3 moElt Corporate Private Limited
Riju Jain
DIN 06698491
Director05 Jul 20197 yrs 3 moElt Corporate Private Limited
Rajul Jain
DIN 06701704
Additional Director20 Oct 20233 yrsElt Corporate Private Limited

Financials of medilawindia

Figures of Elt Corporate Private Limited, the primary company behind medilawindia, for FY 2024. Revenue was ₹1.55 Cr (-19% year on year). Net loss was -₹55.7 Lakh (-36% margin). EBITDA was -₹44.6 Lakh (-29% margin). Revenue has grown at a compounded annual rate of +31% over three years.

  • ₹1.55 CrRevenue · FY 2024 · -19% YoY
  • -₹55.7 LakhNet loss · -36% margin
  • -₹44.6 LakhEBITDA · -29% margin
  • ₹1 LakhPaid-up capital
  • +31%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Elt Corporate Private Limited are on its company page.

Premium access

Detailed financial statements for medilawindia

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about medilawindia

medilawindia was founded in 2021.

medilawindia is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

The primary company behind medilawindia, Elt Corporate Private Limited, reported revenue of β‚Ή1.55 Cr for FY 2024, down 19% year on year.

medilawindia, established in 2021 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, regulatory services, and drug licensing. Provides drug licensing and regulatory support services for the pharmaceutical industry. Adapting to market demands with innovation and client-focused strategies.

medilawindia operates through Elt Corporate Private Limited.

The legal entities of medilawindia currently have 3 directors, including Shruti Jain, Rajul Jain, Riju Jain.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available